Altered systemic cortisol metabolism in bipolar disorder and schizophrenia spectrum disorders

Dysfunction of the hypothalamic-pituitary-adrenal (HPA) axis is suggested as a pathophysiological factor in bipolar disorder and schizophrenia. Increased clearance of cortisol was recently indicated as a component in the HPA axis hyperdrive. The aim of the present study was to test the model of increased cortisol metabolism in a new replication sample separately and combined with a previously published sample of bipolar disorder and schizophrenia. Spot urine was sampled from 212 healthy controls (HC) and 221 patients with a schizophrenia spectrum disorder (SCZ, n = 115) and bipolar disorder (BD, n = 106). Of these, a subsample of 169 HC and 155 patients was included in a previous report. Urinary free cortisol, cortisone and their metabolites were measured, and the activities of 5 alpha-reductase, 5 beta-reductase and 11 beta-HSD were estimated and analyzed for differences between groups. In the new sample, there was increased enzyme activity in SCZ for 5 beta-reductase (p = 0.024 vs HC; p = 0.027 vs BD) and 11 beta-HSD2 (p = 0.014 vs HC; p = 0.004 vs BD). In the combined sample, there was increased activity in SCZ for 5 alpha-reductase (p < 0.001 vs HC; p = 0.020 vs BD), 5 beta-reductase (p < 0.001 vs HC; p = 0.045 vs BD) and 11 beta-HSD2 (p < 0.001 vs HC; p = 0.043 vs BD), and in BD for 5 beta-reductase (p = 0.002), 11 beta-HSD2 (p = 0.039) and 5 alpha-reductase (trend, p = 0.084) (all vs HC). The findings confirm increased systemic cortisol metabolism in BD and SCZ. This is most consistent in SCZ, with BD taking an intermediate position. The design makes it impossible to determine the direction of the effect. However, the findings merit further study of cortisol metabolism as a possible component in the HPA axis dysfunction and pathophysiology of BD and SCZ. (C) 2014 Elsevier Ltd. All rights reserved.